SUMMARY
Arterial hypertension (AH) during pregnancy is a serious problem in obstetric practice, affecting the health of the mother and fetus. Hypertension in pregnancy includes chronic hypertension, gestational hypertension, preeclampsia and eclampsia. The definition of each condition is based on blood pressure levels and the presence of other clinical signs. The article discusses modern approaches to the diagnosis and treatment of hypertension during pregnancy, including classification, risks and monitoring methods.
Keywords: pregnancy, arterial hypertension, preeclampsia, eclampsia, antihypertensive therapy

---

REFERENCES

1. Renata Cífková Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview // High Blood Pressure & Cardiov. Prev., 2023; 30:289-303 doi: 10.1007/s40292-023-00582-5.
2. Клименченко Н.И. Артериальная гипертензия и беременность // Акушерство и гинекология: новости, мнения, обучение, 2017; №2: c.55-65.
3. Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J. et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.
4. Williams B., Mancia G., Spiering W., Agabiti Rosei E. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension // J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.000000000 0001940.
5. Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014; 129(11):1254-1261. doi: 10.1161/CIRCULATIONAHA.113.003904.
6. Ives CW, Sinkey R., Rajapreyar I., Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-theart review // J Am Coll Cardiol. 2020;76(14):1690-702. doi: 10.1016/j.jacc.2020.08.014.
7. Clinical protocols in obstetrics and gynecology. Part II. Ed. by I.E. Zazerskaya. St.Petersburg: Eco-vector, 2016. p. 344. (In Russ.) Клинические протоколы ведения пациентов по специальности “Акушерство и гинекология”. Ч. 2 / под ред. И. Е. Зазерской. СПб.: Эко-вектор, 2016. 344 с.
8. Bartsch E., Medcalf K.E., Park A.L., Ray J.G. High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies // BMJ 2016;353:i1753. doi: 10.1136/bmj.i1753.
9. Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A. et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice // Preg. Hypertens., 2018; 13:291-310. doi: 10.1016/j.preghy. 2018.05.004.
10. Webster K., Fishburn S., Maresh M., Findlay SC, Chappell LC. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366: l5119. doi: 10.1136/bmj.l5119.
11. Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee Opinion Summary, Number 804. Obstet Gynecol. 2020;135(4): p.991-993. doi: 10.1097/AOG.0000000000003773.
12. Santos S., Voerman E., Amiano P., Barros H., Beilin L.J. et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts. BJOG. 2019;126(8):984-995. doi: 10.1111/ 1471-0528.15661.
13. Maxwell C., Gaudet L., Cassir G., Nowik C. et al. Guideline no. 391-pregnancy and maternal obesity part 1: pre-conception and prenatal care // J Obstet Gynaecol Can. 2019;41(11):1623-1640. doi: 10.1016/j.jogc.2019.03.026.
14. Maxwell C., Gaudet L., Cassir G., Nowik C. et al. Guideline no. 392-pregnancy and maternal obesity part 2: team planning for delivery and postpartum care // J. Obstet. Gynaecol Can. 2019;41(11):1660-1675. doi: 10.1016/j.jogc.2019.03.027.
15. Rasmussen K.M., Abrams B., Bodnar L.M. et al. Recommendations for weight gain during pregnancy in the context of the obesity epidemic // Obstet. Gynecol. 2010;116(5):1191-5. doi: 10.1097/AOG.0b013e3181f60da7.
16. Hofmeyr G.J, Lawrie T.A, Atallah Á.N., Torloni M.R. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018;10(10): Cd001059. doi:10.1002/14651858. CD001059.pub5.
17. Henderson J.T., Whitlock E.P., O’Connor E. et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force // Ann. Intern. Med. 2014; 160: 695. doi: 10.7326/M13-2844.
18. Rolnik D.L., Wright D., Poon L.C. et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377 (7): 613-22. doi: 10.1056/ NEJMoa1704559.
19. Pangle B.L. Drugs in Pregnancy and Lactation. In: Herfindal ET, Gourley DR, editors. Text book of Therapeutics, Drug and Disease Management. 8th ed. Philadelphia: Lippincott William Wilkins; 2006. pp. 434-48. doi:10.1258/om. 2009.090002.
20. Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018. Национальные Рекомендации, Российский кардиологический журнал, № 3 (155) | 2018, c.91-134 https://doi.org/10.15829/ 1560-4071-2018-3-91-134.
21. Shekhar S., Gupta N., Kirubakaran R., Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis. BJOG 2016;123:40-47. doi: 10.1111/1471-0528.13463.
22. Clark SM, Dunn HE, Hankins GD. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol 2015;39:548-555. doi: 10.1053/j.semperi.2015.08.011.
23. Altman D., Carroli G., Duley L., Farrell B. et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebo-controlled trial // Lancet. 2002;359(9321): 1877-90. doi: 10.1016/s0140-6736(02)08778-0.
24. Duley L., Gülmezoglu A.M, Henderson-Smart D.J., Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia // Cochrane Database Syst Rev. 2010;(11): Cd000025. doi: 10.1002/14651858.CD000025.pub2.
25. Cífková R, Johnson MR, Kahan T, Brguljan J, Williams B, Coca A, et al. Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension // Eur Heart J Cardiovasc Pharmacother. 2020;6(6):384-393. doi: 10.1093/ehjcvp/pvz082.
26. Абдрахманова А.И. Артериальная гипертензия у беременных/ А.И. Абдрахманова, Ю.В. Ослопова, Р.Н. Хасанова, Н.А. Цибулькин - Казань: Казан. ун-т, 2017. - 70 с.
27. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study // BMJ. 2003;326(7394):845.
28. Søndergaard M.M., Hlatky M.A., Stefanick M.L. et al. Association of adverse pregnancy outcomes with risk of atherosclerotic cardiovascular disease in postmenopausal women // JAMA Cardiol. 2020;5(12):1390-1398. doi:10.1001/ jamacardio.2020.4097.
29. Wu P., Haththotuwa R., Kwok C.S., Babu A. et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2): e003497. doi: 10.1161/ CIRCOUTCOMES.116.003497.
30. Mosca L., Benjamin E.J., Berra K. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a Guideline from the American Heart Association. Circulation 2011;123:1243-1262. doi:10.1161/CIR.0b013e31820faa